Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
作者信息
Kanis J A
机构信息
Centre for Metabolic Bone Diseases at Sheffield (WHO Collaborating Center), University of Sheffield, UK.
出版信息
Osteoporos Int. 1998;8 Suppl 1:S51-6.
PMID:9682799
Abstract
摘要
相似文献
1
Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?雌激素缺乏与激素替代疗法是否分散了骨质疏松症领域的注意力？
Osteoporos Int. 1998;8 Suppl 1:S51-6.
2
Is there a case for targeting hormone replacement therapy for osteoporosis at the menopause?针对更年期骨质疏松症进行激素替代疗法是否有必要？
Osteoporos Int. 1998;8 Suppl 1:S47-50.
3
Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.骨质疏松症与心血管疾病：激素替代疗法的利弊
J Endocrinol Invest. 2005;28(10 Suppl):80-4.
4
Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.长期雌激素及激素替代疗法用于预防和治疗骨质疏松症。
Curr Womens Health Rep. 2003 Jun;3(3):181-6.
5
Evidence-based assessment of pharmaceutical interventions.药物干预措施的循证评估
Osteoporos Int. 1998;8 Suppl 1:S17-21.
6
[Osteoporosis as a cause of pathological fractures].[骨质疏松症作为病理性骨折的一个病因]
Zentralbl Chir. 1990;115(11):645-55.
7
[Bone densitometry and hormone therapy].[骨密度测定与激素治疗]
Pathol Biol (Paris). 1998 May;46(5):291-3.
8
Osteoporosis prevention with sex hormone replacement therapy.采用性激素替代疗法预防骨质疏松症。
Int J Fertil Menopausal Stud. 1994 Sep-Oct;39(5):262-71.
9
[Estrogen replacement therapy in osteoporosis].[骨质疏松症的雌激素替代疗法]
Duodecim. 1996;112(22):2123-9.
10
[Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women].[重新认识绝经后女性长期激素替代疗法的获益与风险]
Zhonghua Fu Chan Ke Za Zhi. 2003 Aug;38(8):487-8.
引用本文的文献
1
A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service.一项基于人群的关于引入新的骨密度检测服务后骨质疏松症检测与治疗的研究。
Osteoporos Int. 2005 Jul;16(7):773-82. doi: 10.1007/s00198-004-1756-5. Epub 2004 Oct 2.
Zotero 插件